UBS Group AG - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 2 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$146,000
+73.8%
7,699
+23.8%
0.00%
Q4 2018$84,000
+21.7%
6,2170.0%0.00%
Q3 2018$69,000
+146.4%
6,217
+9.2%
0.00%
Q4 2016$28,000
+47.4%
5,694
+51.8%
0.00%
Q3 2016$19,000
-17.4%
3,750
-16.5%
0.00%
Q2 2016$23,000
-14.8%
4,493
-2.0%
0.00%
Q1 2016$27,000
-44.9%
4,584
-2.6%
0.00%
Q4 2015$49,000
-15.5%
4,705
+50.0%
0.00%
Q3 2015$58,000
+9.4%
3,136
+16.1%
0.00%
Q2 2015$53,000
-60.4%
2,700
-64.7%
0.00%
Q1 2015$134,000
+109.4%
7,659
+91.5%
0.00%
Q4 2014$64,0004,0000.00%
Other shareholders

There were no reported owners of OSIRIS THERAPEUTICS INC NEW in Q2 2019.

NameSharesValueWeighting ↓
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders